BLUF: The National Institutes of Health (NIH) published a draft policy on September 14, 2026 to overhaul biosafety oversight for federally funded research involving biohazards.

The Department of Health and Human Services (HHS) agency published the notice in the Federal Register, framing it as a modernization of biosafety practice intended to keep pace with evolving research risks. The draft policy would, once finalized, replace the current NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. NIH is soliciting public input before finalizing the replacement policy.

Why it matters: For institutions and contractors that hold NIH funding or perform biosafety-regulated research under federal awards, this is the first comprehensive rewrite of the recombinant/synthetic nucleic acid guidelines in the current policy's lifetime. Organizations with active or pending NIH awards involving biohazard research should track the comment docket, since the replacement policy will set the compliance baseline institutional biosafety committees are held to going forward.

By the numbers:

• Federal Register document number: 2026-18646
• Published: September 14, 2026
• Comment period closes: October 19, 2026
• Issuing components: HHS and NIH
• Document type: Notice

NIH describes itself as the world's largest public funder of biomedical research and says the proposal is meant to ensure oversight of biosafety practices keeps pace with evolving risks in the field. The notice does not yet specify final compliance dates or enforcement mechanics — those details would follow finalization after the comment period closes.

Source: Federal Register